Cargando…
Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors
Accumulating data from patients treated with checkpoint inhibitors and other immunomodulatory agents indicate that harnessing the power of the immune system is integral to achieve improve long-term cancer containment rates and prolong patient survival. Due to their mechanism of action, immunotherape...
Autores principales: | Eggermont, Alexander, Robert, Caroline, Soria, Jean Charles, Zitvogel, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973659/ https://www.ncbi.nlm.nih.gov/pubmed/24719793 http://dx.doi.org/10.4161/onci.27560 |
Ejemplares similares
-
Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’
por: Jacquelot, Nicolas, et al.
Publicado: (2018) -
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
por: Jacquelot, Nicolas, et al.
Publicado: (2018) -
Uveal melanoma: Long-term survival
por: Radivoyevitch, Tomas, et al.
Publicado: (2021) -
Isolated Tumor Cells and Long-Term Prognosis of Patients with Melanoma
por: van Akkooi, A. C. J., et al.
Publicado: (2008) -
Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors
por: Çuburu, Nicolas, et al.
Publicado: (2022)